National Institutes of Health Clinical Center (CC)
nih.govLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
368
Capped at 5,000
Active
34
Phase 3
7
Total enrollment
30,691,686
Pipeline matrix
Showing 11 of 11 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| filgrastim | — | — | — | 8 | |||
| Dexamethasone | — | — | — | — | 2 | ||
| Endotoxin | — | — | — | — | 2 | ||
| Mycophenolate Mofetil | — | — | — | — | — | 1 | |
| Tacrolimus | — | — | — | — | — | 1 | |
| Post-Transplant Cyclophosphamide | — | — | — | — | — | 1 | |
| Briquilimab | — | — | — | — | — | 1 | |
| Spironolactone | — | — | — | — | — | 1 | |
| cyclophosphamide | — | — | 14 | ||||
| Fludarabine | — | — | — | — | 3 | ||
| [18F]-Fluorocellobiose | — | — | — | — | — | 1 |
Next readouts
- 2025-10-16
- 2026-12-31
- 2027-06-30
- 2029-06-30
- 2032-01-01
Top conditions
- Healthy33
- Unspecified Adult Solid Tumor, Protocol Specific19
- Lymphoma17
- Liver Cancer13
- Melanoma (Skin)12
- Healthy Volunteers12
- Breast Cancer11
- Kidney Cancer10
Frequently asked questions about National Institutes of Health Clinical Center (CC)
- How many clinical trials does National Institutes of Health Clinical Center (CC) have on ClinicalTrials.gov?
- National Institutes of Health Clinical Center (CC) is listed as the lead sponsor on 368 clinical trials in ClinicalTrials.gov, 34 of which are currently active (recruiting, enrolling, or ongoing).
- How many of National Institutes of Health Clinical Center (CC)'s trials are in Phase 3?
- 7 of National Institutes of Health Clinical Center (CC)'s trials are in Phase 3, spread across 11 active drug programs.
- What therapeutic areas does National Institutes of Health Clinical Center (CC) focus on?
- National Institutes of Health Clinical Center (CC)'s most-studied conditions on ClinicalTrials.gov are Healthy, Unspecified Adult Solid Tumor, Protocol Specific, Lymphoma, Liver Cancer, Melanoma (Skin).
- When are National Institutes of Health Clinical Center (CC)'s next clinical trial readouts?
- National Institutes of Health Clinical Center (CC) has 5 upcoming primary-completion readouts tracked here; the soonest is “Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency”, expected around 2025-10-16.